Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Author(s):
Burn, J.; Gerdes, A.M.; Macrae, F.; Mecklin, J.P.; Moeslein, G.; Olschwang, S.; Eccles, D.; Evans, D.G.; Maher, E.R.; Bertario, L.; Bisgaard, M.L.; Dunlop, M.G.; Ho, J.W.C.; Hodgson, S.V.; Lindblom, A.; Lubinski, J.; Morrison, P.J.; Murday, V.; Ramesar, R.; Side, L.; Scott, R.J.; Thomas, H.J.W.; Vasen, H.F.; Barker, G.; Crawford, G.; Elliott, F.; Movahedi, M.; Pylvanainen, K.; Wijnen, J.T. (0000-0003-2805-6922); Fodde, R.; Lynch, H.T.; Mathers, J.C.; Bishop, D.T.; CAPP2 Investigators
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-12-17
Language
English
Is part of
Lancet (2011), Vol. 378, no. 9809, p. 2081-2087
hdl
1887/108493
doi
10.1016/S0140-6736(11)61049-0